121 CFR 211.68, clause by clause.
Section 211.68 covers “Automatic, mechanical, and electronic equipment”, not only computers: (a) allows it under a written programme of checks, (b) controls computer records, and (c) says when equipment can replace one of two people.¹
| Clause | What it requires |
|---|---|
| (a) Use | Equipment that performs a function satisfactorily may be used, including computers |
| (a) Checks | Routine calibration, inspection or checking under a written programme; written records kept |
| (b) Access | Changes to master production and control records and other records made only by authorised personnel |
| (b) Input and output | Checked for accuracy; degree and frequency set by the system’s complexity and reliability |
| (b) Backup | A backup file of data that is exact, complete and secure from alteration, inadvertent erasure or loss |
| (b) Eliminated data | Where computation removes data, a written record of the program and appropriate validation data |
| (c) One-person check | For five listed operations, equipment can perform the step if one person checks it did so properly |
Paragraph (c) came with a 2008 rule, effective 8 December 2008.² FDA reads “systems” broadly: people, machines and methods, from hardware, software and networks to personnel and SOPs.³
Part 211 never says “audit trail”, yet FDA’s Q&A expects audit trails reviewed with the record, citing among others 211.101(c) and (d), 211.103 and 211.182, the operations paragraph (c) covers.³⁴ See audit trail requirements and Part 11 requirements.
221 CFR 211.68 records checklist.
These are the records an inspector can ask for under paragraphs (a) and (b), plus the restore test EU GMP asks for, and the evidence to have before relying on (c).
| Record | What it shows | Usual owner | Requirement |
|---|---|---|---|
| Checks programme | Each automatic, mechanical or electronic item, its calibration, inspection or check, and results. No interval is set; laboratory instruments also need calibration “at suitable intervals” | Engineering or metrology | 211.68(a);¹ 211.160(b)(4)⁴ |
| Workflow validation | Each CGMP workflow validated for its intended use, calculations included | System owner and QA | DI Q&A Q3³ |
| Access list | Authorised people per system; administrators independent of the record content; unique logins | System owner | 211.68(b);¹ DI Q&A Q4 and Q5³ |
| Input/output checks | The scheme, why its depth suits the system, and the results; input edits can reduce manual checks | System owner | 211.68(b);¹ CPG 425.400⁵ |
| Eliminated data | The program that removes data, and its validation data | System owner | 211.68(b)¹ |
| Backup | A true copy with its metadata, kept for the retention period | IT | 211.68(b);¹ DI Q&A Q1e³ |
| Restore test | Restore proved during validation and checked periodically; in the US, the evidence that the backup is a usable true copy | IT and QA | Annex 11 7.2;⁶ DI Q&A Q1e³ |
| Audit trail review | Reviewed by whoever reviews the record, at the same frequency | Record reviewers | DI Q&A Q7 and Q8³ |
| One-person check | Evidence the system examines what a person would, at least as accurately; checks of the initial, branching and final steps recorded; a named, trained checker | Production and QA | 211.68(c);¹ CPG 425.500;⁷ 2008 rule² |
Two edge cases come from FDA’s Q&A. “Temporary backup copies (e.g., in case of a computer crash or other interruption) would not satisfy the requirement”, and shared, read-only accounts are acceptable for viewing data but “do not conform with the part 211 and 212 requirements for actions, such as second person review, to be attributable to a specific individual.”³
3When a system can replace the second person.
Paragraph (c) names five rules that ask for one person to do a step and another to check it. In each, equipment used in line with the section can take the first person’s place; it never takes the checker’s.¹²
| Operation | Section | With automation | What stays human |
|---|---|---|---|
| Dispensing check | 211.101(c) | One person, if equipment weighs, measures or subdivides | Assuring release, weight and identification |
| Component addition | 211.101(d) | Added by equipment, verified by one person | The verification |
| Yield calculation | 211.103 | Calculated by equipment, verified by one person | Independent verification |
| Cleaning log | 211.182 | Only the person verifying automated cleaning and maintenance signs | The verification and signature |
| Significant steps | 211.188(b)(11) | Record the person checking the automated step | The check |
| Master record | 211.186(a) | Not covered: two people | Both signatures, which may be electronic |
| Laboratory record | 211.194(a)(8) | Not covered: second-person review | The review |
| Batch record issue | 211.188(a) | Not covered; needs only one check | A person verifies the issued record |
| Hand-applied labels | 211.122(g)(3) | Not covered; 100% electronic examination is a separate option | Independent second verification |
FDA declined requests in 2008 to let equipment check work a person had done, including a barcode scan confirming an ingredient a person added:
“Revised Sec. 211.101(c) only permits human checking of weighing, measuring, and subdividing operations performed by automated equipment; we did not propose to allow automated checking of these operations.” Final rule, 73 FR 51919, 8 September 2008²
So under 211.101(d) an addition made by a person still needs a second person to verify it, scan or no scan.²⁴
The check is of the equipment, not a repeat of its work. In the same rule, “the person doing the checking must verify that the automated equipment is functioning properly and that the operations are reliably performed in the intended manner”, and FDA does not expect that a person will normally need “to repeat all of the automatic calculations by hand”.² The level, nature and frequency of that check can vary with the level of automation, and the 2008 amendments were “not intended to either add to or detract from any existing requirements”.²
FDA’s 1982 CPG 425.500 accepts a validated system that performs, supervises or checks significant steps, with checks of the initial, branching and final steps in the batch record.⁷ That does not take the person out of the check. In 2008 FDA rejected the reading that the CPG “allows for elimination of human oversight”: “a person, rather than automated equipment, is needed to record these checks of production steps in batch records”, and “All automated systems require some level (commensurate with the complexity and risk inherent in the system) of human oversight or checking for expected performance at appropriate intervals.”²
3.1Cleaning and charging: what FDA answered in 2008.
- Starting a CIP cycle is not performing it. FDA does not believe “that initiation of the automated cleaning cycle by a human operator constitutes performance of the cleaning process”, so only the person verifying the completed cycle signs the 211.182 log, for “both portable equipment skids and fixed equipment”.²
- Outputs are not the whole check. Equipment outputs “will normally be key factors, but not necessarily the only ones”. Manufacturers should “determine the reliability of the outputs and periodically check them”, for example by checking that an alarm works, monitoring the cleaning supplies a cycle uses or checking the rinse independently.²
- Fully automated additions still get a person. For a liquid line charged by equipment, where only the equipment’s own outputs show what went in, FDA still wanted “human verification that components were properly added to the liquid production line by the automated equipment”. For continuous additions it expects “a suitable system of human oversight”, not a witness for each one.²
4Example: an automated weigh and dispense.
Batch 26-208 calls for 12.400 kg of microcrystalline cellulose, with a tolerance of ±0.5%: 12.400 × 0.005 = 0.062 kg, so 12.338 to 12.462 kg.
| Step | Performed by | Checked by | Record |
|---|---|---|---|
| Container and status | eBR scans the container against the bill of materials and QC release | Operator confirms the label | Lot, status, scan time |
| Balance readiness | Daily check on balance BAL-07 passed; calibration in date | Operator reviews on screen | Check result, calibration due date |
| Weighing | Interface captures gross 13.235 kg, tare 0.820 kg, net 12.415 kg | Covered by the step check | Raw values, device, time |
| Tolerance | eBR compares 12.415 kg with 12.338 to 12.462 kg: pass | Covered by the step check | Result |
| Label | eBR prints name, lot, net weight and batch | Operator compares label and screen | Label content |
| Check of the step | Not applicable | One trained person, who may be the operator: no alarms, interface online, values in limits | Name and e-signature covering 211.101(c)(1) to (3) and 211.188(b)(11) |
| Manual fallback | Interface down; operator types the weight | A second person examines the container | Two signatures, 211.101(c) |
The last row is a judgement, not a quoted rule. The 2008 rule does not mention typed weights, but 211.101(c)(3) relieves the second person only when the weighing is “performed by automated equipment”, and once a person reads and types the number, the weight “correct as stated in the batch production records” rests on that person. The conservative reading, and the one consistent with FDA’s refusal to let equipment check human work, is to bring the second person back.⁴² See potency-adjusted dispensing for the calculation that often sits upstream.
5Example: an input/output and backup-restore record.
| Field | Entry |
|---|---|
| System | MES-01, release 7.2, used for dispensing and batch records |
| Input/output scheme | Every master record change: all formula quantities compared with the approved formula. Weekly: 10 interfaced weighings compared with balance printouts |
| Rationale | Interface with no failures in 18 months; range and unit edits block implausible entries. The weekly comparison is the periodic check on output reliability FDA described in 2008 |
| Week 44 result | 10 of 10 match to 0.001 kg |
| Backup | Nightly full backup to a second site, kept for the record retention period |
| Restore test | 3 November 2026, after the backup tool upgrade under change CC-26-118: the 1 November backup restored to a test environment |
| Restore result | 1,240 batch records on both sides; 20 sampled records match field by field, including signatures and audit trail entries |
| Approval | IT owner and QA, 5 November 2026 |
6How EU GMP compares.
| Topic | 21 CFR 211.68 | EU GMP |
|---|---|---|
| Dispensing check | Equipment weighs; one person checks it | Each dispensed material and its weight or volume independently checked |
| Who checks | A person, never the system | 5.38 does not say |
| Typed critical data | Input checked; input edits can reduce manual checks | A second operator or validated electronic means |
| Backup | Exact, complete, secure backup file | Restore checked in validation and periodically; the draft adds after changes |
Keep two checks apart. For typed entries, both regions accept automated checks: Annex 11 section 6 says “This check may be done by a second operator or by validated electronic means”, and FDA’s CPG 425.400 says efficient input edits “could mitigate the need for more detailed manual data checks”.⁶⁵ The check of the dispensed material is different: EU GMP 5.38 wants it “independently checked and the check recorded” without saying by whom, while FDA’s 2008 rule makes the check of an operation human.⁸²
APIs sit between. Part 211 covers drug products, which Part 210 defines as finished dosage forms, and FDA adopted ICH Q7 as final guidance in September 2016.⁴¹⁰¹¹ Q7 5.45 says the check on manually entered critical data “can be done by a second operator or by the system itself”, so a US API maker can rely on the system there, while 211.68(c) and the 2008 refusal bind finished-dosage makers.¹² PIC/S PE 009-18 carries the same Annex 11 text, and the UK keeps applying the EU guidelines as they stood at the end of 2020, the 2011 Annex 11 among them.¹³¹⁴
The July 2025 draft Annex 11 drops the second operator and asks systems to check that manually entered critical data are plausible.⁹ It is still a draft; see the Annex 11 revision.
7What inspectors cite.
“Furthermore, your firm did not adequately maintain backups of data generated by your laboratory equipment.” NWL Netherlands Services B.V., warning letter 320-25-59, 1 April 2025¹⁵
“Your firm confirmed that you did not back up the electronic data located on the GC computer.” Laboratorios Jaloma S.A. de C.V., warning letter 320-26-78, 22 May 2026¹⁶
“These deficiencies demonstrate your failure to maintain a robust program to assure the proper performance of equipment essential to the manufacturing, processing, and holding of your drug products.” Granules India Limited, warning letter 320-25-48, 26 February 2025¹⁷
The Granules finding concerned air handling units and HEPA filters, cited under 211.68(a): the paragraph reaches far beyond computers.¹⁷
8How it runs in Seal.
In Seal, weigh and dispense records the container scan, the gross, tare and net readings and the verification against the batch step, with the original values retained. Configure the balance connection to keep device identity and calibration status with each capture. Before go-live, test it for disconnection, stale readings, unit changes and invalid values; any permitted manual fallback needs its own attribution and review. A failed identity check stays on the record beside a passing weight, so a correct number alone does not complete the step.
Validation follows the same proportion as the rule: computer system assurance starts from intended use and function risk, links supplier evidence, the configuration baseline, testing and release, and assesses each change from what moved. Neil can draft dispensing checks with their failure cases; the manufacturing owner verifies devices, units and exception behaviour and releases the workflow under change control.
References
- 121 CFR 211.68, Automatic, mechanical, and electronic equipment, paragraphs (a) to (c) and amendment history, eCFR, current to 5 November 2026. https:/
/ www. ecfr. gov/ current/ title- 21/ section- 211. 68 (read 8 November 2026) - 2Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals, final rule, 73 FR 51919, effective 8 December 2008, comments 19 to 30, 34, 38 and 39, full text searched for “manual”, FDA, 8 September 2008. https:/
/ www. govinfo. gov/ content/ pkg/ FR- 2008- 09- 08/ html/ E8- 20709. htm (read 8 November 2026) - 3Data Integrity and Compliance With Drug CGMP: Questions and Answers, guidance for industry, questions 1c, 1e, 1f, 3, 4, 5, 7, 8 and 11, FDA, December 2018. https:/
/ www. fda. gov/ media/ 119267/ download (read 8 November 2026) - 421 CFR Part 211, sections 211.1(a), 211.101, 211.103, 211.122(g), 211.160(b)(4), 211.182, 211.186(a), 211.188 and 211.194(a)(8), full text searched for “audit trail”, eCFR, current to 5 November 2026. https:/
/ www. ecfr. gov/ current/ title- 21/ chapter- I/ subchapter- C/ part- 211 (read 8 November 2026) - 5CPG Sec. 425.400, Computerized Drug Processing; Input/Output Checking, FDA, issued 20 September 1982, reissued 4 September 1987. https:/
/ www. fda. gov/ regulatory- information/ search- fda- guidance- documents/ cpg- sec- 425400- computerized- drug- processing- inputoutput- checking (read 8 November 2026) - 6EudraLex Volume 4, Annex 11: Computerised Systems, sections 5, 6, 7.2 and 9, European Commission, January 2011. https:/
/ health. ec. europa. eu/ system/ files/ 2016- 11/ annex11_ 01- 2011_ en_ 0. pdf (read 8 November 2026) - 7CPG Sec. 425.500, Computerized Drug Processing; Identification of “Persons” on Batch Production and Control Records, policy and note, FDA, issued 2 November 1982, reissued 4 September 1987. https:/
/ www. fda. gov/ regulatory- information/ search- fda- guidance- documents/ cpg- sec- 425500- computerized- drug- processing- identification- persons- batch- production- and- control (read 8 November 2026) - 8EudraLex Volume 4, Part I, Chapter 5: Production, section 5.38, European Commission, in operation since 1 March 2015. https:/
/ health. ec. europa. eu/ system/ files/ 2016- 11/ chapter_ 5_ 0. pdf (read 8 November 2026) - 9Annex 11: Computerised Systems, draft for consultation, sections 10.1, 10.2 and 16.6, full text searched for “operator”, European Commission and PIC/S, July 2025. https:/
/ health. ec. europa. eu/ document/ download/ 40231f18- e564- 4043- 94de- c031f813d38b_ en?filename=mp_ vol4_ chap4_ annex11_ consultation_ guideline_ en. pdf (read 8 November 2026) - 1021 CFR 210.3(b)(4), definition of drug product, eCFR, current to 5 November 2026. https:/
/ www. ecfr. gov/ current/ title- 21/ chapter- I/ subchapter- C/ part- 210/ section- 210. 3 (read 8 November 2026) - 11Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, guidance for industry, final, FDA, September 2016. https:/
/ www. fda. gov/ regulatory- information/ search- fda- guidance- documents/ q7- good- manufacturing- practice- guidance- active- pharmaceutical- ingredients- guidance- industry (read 8 November 2026) - 12ICH Q7, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, section 5.45, ICH, 10 November 2000. https:/
/ database. ich. org/ sites/ default/ files/ Q7%20Guideline. pdf (read 8 November 2026) - 13PE 009-18 (Annexes), Guide to Good Manufacturing Practice for Medicinal Products, Annex 11, sections 6, 7.2 and 9, PIC/S, in force 24 September 2026. https:/
/ picscheme. org/ docview/ 11333 (read 8 November 2026) - 14The Human Medicines Regulations 2012 (SI 2012/1916), regulation C17(3), legislation.gov.uk, up to date to 7 November 2026. https:/
/ www. legislation. gov. uk/ uksi/ 2012/ 1916/ regulation/ C17 (read 8 November 2026) - 15NWL Netherlands Services B.V., warning letter 320-25-59, FDA, 1 April 2025. https:/
/ www. fda. gov/ inspections- compliance- enforcement- and- criminal- investigations/ warning- letters/ nwl- netherlands- services- bv- 701206- 04012025 (read 8 November 2026) - 16Laboratorios Jaloma S.A. de C.V., warning letter 320-26-78, MARCS-CMS 725939, FDA, 22 May 2026. https:/
/ www. fda. gov/ inspections- compliance- enforcement- and- criminal- investigations/ warning- letters/ laboratorios- jaloma- sa- de- cv- 725939- 05222026 (read 8 November 2026) - 17Granules India Limited, warning letter 320-25-48, FDA, 26 February 2025. https:/
/ www. fda. gov/ inspections- compliance- enforcement- and- criminal- investigations/ warning- letters/ granules- india- limited- 697115- 02262025 (read 8 November 2026)
AQuestions and answers
How often must backups be restored and tested?
Neither Part 211 nor Annex 11 sets a fixed interval. EU Annex 11 asks for the ability to restore to be checked during validation and monitored periodically, and the 2025 draft adds a restore test after any change to the backup or restore process or tools. FDA expects the backup to be a true copy kept for the whole retention period, and a restore test is the direct way to show the copy is exact and complete. Set the interval by risk and record each test.
Can the operator be the person who checks the automated step?
Yes. FDA said in the 2008 rule that the person verifying an automated operation may be, but need not be, the operator. Whoever does it must have the training to perform the check, and the batch record must identify them.
Does 21 CFR 211.68 require computer system validation?
Only indirectly. The section uses the word once, for programs that eliminate data, but FDA reads 211.68(b) with 211.63 and 211.110(a) as requiring each CGMP workflow on a computer system to be validated for its intended use, with effort matched to risk. Qualifying a platform such as an MES is not enough on its own; the master record’s calculations need validating too.
How does 21 CFR 211.68 relate to Part 11?
They overlap but answer different questions. Section 211.68 is a predicate rule about the equipment and computer systems used in manufacture: checks, access, input and output, and backup. Part 11 applies to the electronic records and signatures that Part 211 requires, with its own controls such as audit trails. A batch record system usually has to meet both.
